Company / Operating Income per Share
SELLAS Life Sciences Group, Inc. Operating Income per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.51
FY2024
5-year range
-$3.34 / -$0.51
FY2020-FY2024
Trend
+71.4%
vs FY2023
Sector context
#76 of 201
Health Care
What the data says
At $-0.51, SELLAS Life Sciences Group, Inc.'s operating income per share ranks #76 of 201 in the Health Care sector. Operating Income per Share returned to growth in FY2024 after 2 years of decline, reaching $-0.51.
Based on SEC 10-K filings.
-0.51 in FY2024.
Improved from $-1.59 to $-0.51 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#76 of 201 in Health CareTop 38% of 201This company -$0.51 Sector average -$28.56
▼
+98.2% above sector average
Key checks
Key Insights
- In FY2024, operating income per share increased 71.4% year-over-year.
- Ranks #76 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2015.
- Lowest operating income per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$0.51 | +71.4% |
| FY2023 | -$1.80 | -13.3% |
| FY2022 | -$1.59 | -33.6% |
| FY2021 | -$1.19 | +64.4% |
| FY2020 | -$3.34 | +57.3% |
| FY2019 | -$7.83 | - |
| FY2018 | - | - |
| FY2017 | -$9.84 | -398.4% |
| FY2016 | -$1.97 | -531.5% |
| FY2015 | -$0.31 | +22.1% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026